Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VARUZHAN MOVSESYAN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1326196809
CMS profile
15431
Location
GLENDALE, AZ

General Payments · PY2018–2024

$3,844.34

  • Reported across 208 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$538.63

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $538.63 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $209.10 7
ABBVIE INC. $143.51 20
PFIZER INC. $45.12 2
PAINTEQ LLC $34.46 1
Novo Nordisk AS $29.88 2
Edwards Lifesciences Corporation $25.41 1
Exact Sciences Corporation $17.54 1
Bayer HealthCare Pharmaceuticals Inc. $17.53 1
GlaxoSmithKline, LLC. $16.08 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $278.68 25
PY2019 $125.15 6
PY2020 $146.75 9
PY2021 $199.29 11
PY2022 $902.21 48
PY2023 $1,653.63 73
PY2024 $538.63 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $7.43 04/03/2024 Food and Beverage Undisputed 01/23/2026 1105075137 CMS
ABBVIE INC. $6.12 05/02/2024 Food and Beverage Undisputed 01/23/2026 1105075139 CMS
ABBVIE INC. $13.96 05/07/2024 Food and Beverage Undisputed 01/23/2026 1105075141 CMS
ABBVIE INC. $8.65 05/21/2024 Food and Beverage Undisputed 01/23/2026 1105075143 CMS
ABBVIE INC. $7.82 06/18/2024 Food and Beverage Undisputed 01/23/2026 1105075145 CMS
ABBVIE INC. $8.98 07/23/2024 Food and Beverage Undisputed 01/23/2026 1105075147 CMS
ABBVIE INC. $11.99 07/31/2024 Food and Beverage Undisputed 01/23/2026 1105075149 CMS
ABBVIE INC. $4.75 07/31/2024 Food and Beverage Undisputed 01/23/2026 1105075151 CMS
ABBVIE INC. $9.80 08/06/2024 Food and Beverage Undisputed 01/23/2026 1105075153 CMS
ABBVIE INC. $7.23 08/20/2024 Food and Beverage Undisputed 01/23/2026 1105075155 CMS
ABBVIE INC. $2.56 09/11/2024 Food and Beverage Undisputed 01/23/2026 1105075157 CMS
ABBVIE INC. $6.59 09/25/2024 Food and Beverage Undisputed 01/23/2026 1105075159 CMS
ABBVIE INC. $6.77 10/10/2024 Food and Beverage Undisputed 01/23/2026 1105075161 CMS
ABBVIE INC. $6.75 10/16/2024 Food and Beverage Undisputed 01/23/2026 1105075163 CMS
ABBVIE INC. $6.04 10/30/2024 Food and Beverage Undisputed 01/23/2026 1105075165 CMS
ABBVIE INC. $6.90 11/14/2024 Food and Beverage Undisputed 01/23/2026 1105075167 CMS
ABBVIE INC. $8.88 12/02/2024 Food and Beverage Undisputed 01/23/2026 1105075169 CMS
ABBVIE INC. $5.79 12/03/2024 Food and Beverage Undisputed 01/23/2026 1105075171 CMS
ABBVIE INC. $4.79 12/10/2024 Food and Beverage Undisputed 01/23/2026 1105075173 CMS
ABBVIE INC. $1.71 12/10/2024 Food and Beverage Undisputed 01/23/2026 1105075175 CMS
AstraZeneca Pharmaceuticals LP $123.13 02/07/2024 Food and Beverage Undisputed 01/23/2026 1104349528 CMS
AstraZeneca Pharmaceuticals LP $14.27 06/13/2024 Food and Beverage Undisputed 01/23/2026 1104736231 CMS
AstraZeneca Pharmaceuticals LP $15.02 07/18/2024 Food and Beverage Undisputed 01/23/2026 1104469480 CMS
AstraZeneca Pharmaceuticals LP $14.91 07/31/2024 Food and Beverage Undisputed 01/23/2026 1105473931 CMS
AstraZeneca Pharmaceuticals LP $13.87 11/14/2024 Food and Beverage Undisputed 01/23/2026 1105242746 CMS
AstraZeneca Pharmaceuticals LP $13.89 11/26/2024 Food and Beverage Undisputed 01/23/2026 1104248287 CMS
AstraZeneca Pharmaceuticals LP $14.01 12/18/2024 Food and Beverage Undisputed 01/23/2026 1104400301 CMS
Bayer Healthcare Pharmaceuticals Inc. $17.53 10/08/2024 Food and Beverage Undisputed 01/23/2026 1086127056 CMS
Edwards Lifesciences Corporation $25.41 04/11/2024 Food and Beverage Undisputed 01/23/2026 1138832514 CMS
Exact Sciences Corporation $17.54 07/24/2024 Food and Beverage Undisputed 01/23/2026 1114798943 CMS
GlaxoSmithKline, LLC. $16.08 08/29/2024 Food and Beverage Undisputed 01/23/2026 1116602721 CMS
Novo Nordisk Inc $13.68 09/05/2024 Food and Beverage Undisputed 01/23/2026 1096875238 CMS
Novo Nordisk Inc $16.20 10/24/2024 Food and Beverage Undisputed 01/23/2026 1096848750 CMS
PAINTEQ LLC $34.46 03/28/2024 Food and Beverage Undisputed 01/23/2026 1142000294 CMS
PFIZER INC. $20.99 03/28/2024 Food and Beverage Undisputed 01/23/2026 1131233177 CMS
PFIZER INC. $24.13 05/15/2024 Food and Beverage Undisputed 01/23/2026 1131520107 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.